Menarini, Group

Menarini Group y MEDSIR presentan el estudio de fase III ADELA

Published on 08/07/2025 at 18:04 | prnewswire.co.uk

Menarini Industrie Farmaceutiche Riunite United Kingdom United States of America France Germany Spain Italy Switzerland Netherlands Belgium Austria

en | boerse | 67981330 |